Literature DB >> 24939588

Linking genotypes database with locus-specific database and genotype-phenotype correlation in phenylketonuria.

Sarah Wettstein1, Jarl Underhaug2, Belen Perez3, Brian D Marsden4, Wyatt W Yue4, Aurora Martinez2, Nenad Blau5.   

Abstract

The wide range of metabolic phenotypes in phenylketonuria is due to a large number of variants causing variable impairment in phenylalanine hydroxylase function. A total of 834 phenylalanine hydroxylase gene variants from the locus-specific database PAHvdb and genotypes of 4181 phenylketonuria patients from the BIOPKU database were characterized using FoldX, SIFT Blink, Polyphen-2 and SNPs3D algorithms. Obtained data was correlated with residual enzyme activity, patients' phenotype and tetrahydrobiopterin responsiveness. A descriptive analysis of both databases was compiled and an interactive viewer in PAHvdb database was implemented for structure visualization of missense variants. We found a quantitative relationship between phenylalanine hydroxylase protein stability and enzyme activity (r(s) = 0.479), between protein stability and allelic phenotype (r(s) = -0.458), as well as between enzyme activity and allelic phenotype (r(s) = 0.799). Enzyme stability algorithms (FoldX and SNPs3D), allelic phenotype and enzyme activity were most powerful to predict patients' phenotype and tetrahydrobiopterin response. Phenotype prediction was most accurate in deleterious genotypes (≈ 100%), followed by homozygous (92.9%), hemizygous (94.8%), and compound heterozygous genotypes (77.9%), while tetrahydrobiopterin response was correctly predicted in 71.0% of all cases. To our knowledge this is the largest study using algorithms for the prediction of patients' phenotype and tetrahydrobiopterin responsiveness in phenylketonuria patients, using data from the locus-specific and genotypes database.

Entities:  

Mesh:

Year:  2014        PMID: 24939588      PMCID: PMC4326710          DOI: 10.1038/ejhg.2014.114

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  41 in total

1.  Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase.

Authors:  S C Kwok; F D Ledley; A G DiLella; K J Robson; S L Woo
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

2.  Recombinant human phenylalanine hydroxylase is a substrate for the ubiquitin-conjugating enzyme system.

Authors:  A P Døskeland; T Flatmark
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 3.  Monogenic traits are not simple: lessons from phenylketonuria.

Authors:  C R Scriver; P J Waters
Journal:  Trends Genet       Date:  1999-07       Impact factor: 11.639

4.  Quantification of the importance of individual steps in the control of aromatic amino acid metabolism.

Authors:  M Salter; R G Knowles; C I Pogson
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

Review 5.  In vitro expression analysis of mutations in phenylalanine hydroxylase: linking genotype to phenotype and structure to function.

Authors:  P J Waters; M A Parniak; P Nowacki; C R Scriver
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

6.  Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

Authors:  S Kure; D C Hou; T Ohura; H Iwamoto; S Suzuki; N Sugiyama; O Sakamoto; K Fujii; Y Matsubara; K Narisawa
Journal:  J Pediatr       Date:  1999-09       Impact factor: 4.406

7.  Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations.

Authors:  E Kayaalp; E Treacy; P J Waters; S Byck; P Nowacki; C R Scriver
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

8.  Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations.

Authors:  Heidi Erlandsen; Angel L Pey; Alejandra Gámez; Belén Pérez; Lourdes R Desviat; Cristina Aguado; Richard Koch; Sankar Surendran; Stephen Tyring; Reuben Matalon; Charles R Scriver; Magdalena Ugarte; Aurora Martínez; Raymond C Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

9.  Recurrence of the R408W mutation in the phenylalanine hydroxylase locus in Europeans.

Authors:  R C Eisensmith; A A Goltsov; C O'Neill; L A Tyfield; E I Schwartz; A I Kuzmin; S S Baranovskaya; G L Tsukerman; E Treacy; C R Scriver
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype.

Authors:  P Guldberg; F Rey; J Zschocke; V Romano; B François; L Michiels; K Ullrich; G F Hoffmann; P Burgard; H Schmidt; C Meli; E Riva; I Dianzani; A Ponzone; J Rey; F Güttler
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

View more
  26 in total

1.  Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.

Authors:  Allison F McCague; Karen S Raraigh; Matthew J Pellicore; Emily F Davis-Marcisak; Taylor A Evans; Sangwoo T Han; Zhongzhou Lu; Anya T Joynt; Neeraj Sharma; Carlo Castellani; Joseph M Collaco; Mary Corey; Michelle H Lewis; Chris M Penland; Johanna M Rommens; Anne L Stephenson; Patrick R Sosnay; Garry R Cutting
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

2.  Structure of full-length human phenylalanine hydroxylase in complex with tetrahydrobiopterin.

Authors:  Marte Innselset Flydal; Martín Alcorlo-Pagés; Fredrik Gullaksen Johannessen; Siseth Martínez-Caballero; Lars Skjærven; Rafael Fernandez-Leiro; Aurora Martinez; Juan A Hermoso
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

3.  Tetrahydrobiopterin treatment reduces brain L-Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice.

Authors:  Tanja Scherer; Gabriella Allegri; Christineh N Sarkissian; Ming Ying; Hiu Man Grisch-Chan; Anahita Rassi; Shelley R Winn; Cary O Harding; Aurora Martinez; Beat Thöny
Journal:  J Inherit Metab Dis       Date:  2018-03-08       Impact factor: 4.982

4.  Characterization of Phenyalanine Hydroxylase Gene Mutations in Chilean PKU Patients.

Authors:  V Hamilton; L Santa María; K Fuenzalida; P Morales; L R Desviat; M Ugarte; B Pérez; J F Cabello; V Cornejo
Journal:  JIMD Rep       Date:  2017-12-30

Review 5.  New protein structures provide an updated understanding of phenylketonuria.

Authors:  Eileen K Jaffe
Journal:  Mol Genet Metab       Date:  2017-06-15       Impact factor: 4.797

6.  Follow-up of two newborns with c.158G>A (p.Arg53His) mutation in gene and assessment of the site function.

Authors:  Jie Wang; Bo Zhu; Lichun Zhang; Yitong Zhao; Xiaohua Wang; Yueqi Jia
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

7.  First structure of full-length mammalian phenylalanine hydroxylase reveals the architecture of an autoinhibited tetramer.

Authors:  Emilia C Arturo; Kushol Gupta; Annie Héroux; Linda Stith; Penelope J Cross; Emily J Parker; Patrick J Loll; Eileen K Jaffe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

Review 8.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

Review 9.  Towards Increasing the Clinical Relevance of In Silico Methods to Predict Pathogenic Missense Variants.

Authors:  David L Masica; Rachel Karchin
Journal:  PLoS Comput Biol       Date:  2016-05-12       Impact factor: 4.475

10.  Structural basis for ligand-dependent dimerization of phenylalanine hydroxylase regulatory domain.

Authors:  Dipali Patel; Jolanta Kopec; Fiona Fitzpatrick; Thomas J McCorvie; Wyatt W Yue
Journal:  Sci Rep       Date:  2016-04-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.